{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:16:43Z","timestamp":1768465003310,"version":"3.49.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in patients with obesity and diabetes and can lead to serious complications. This study aimed to evaluate fundus photographs using artificial intelligence to explore the relationships between diabetic retinopathy (DR), MASLD, and related factors. In this cross-sectional study, we included 1,736 patients with a history of diabetes treatment or glycated hemoglobin (HbA1c) levels of \u22656.5%. All participants were negative for hepatitis B surface antigen and hepatitis C virus antibody and were selected from 33,022 examinees at a health facility in Japan. Fundus photographs were analyzed using RetCAD software, and DR scores were quantified. The presence of DR was determined using two cutoffs: sensitivity (CO20) and specificity (CO50). Steatotic liver (SL) stages were assessed via ultrasound and fibrosis indices and classified into three groups: no SL (SL0), SL with low fibrosis (SL1), and SL with high fibrosis (SL2). Odds ratios (ORs) for the risk of DR associated with each SL stage were calculated using logistic regression, adjusted for age, sex, body mass index, HbA1c, C-reactive protein level, and alcohol consumption. The risk of DR was lower in the SL1 (OR: 0.63, 0.54) and SL2 (OR: 0.64, 0.77) groups compared to the SL0 group at CO20 for both the Fibrosis-4 Index (FIB-4) and the non-alcoholic fatty liver disease fibrosis score (NFS), respectively. Additionally, higher levels of cholinesterase were consistently associated with a reduced risk of DR (FIB-4: OR 0.52, NFS: OR 0.54) at CO50. This study demonstrates that MASLD was associated with a reduced risk of DR, with cholinesterase levels providing further protective effects, highlighting the need for further research into the protective mechanisms and refinement of DR evaluation techniques. The standardized AI evaluation method for DR offers a reliable approach for analyzing retinal changes.<\/jats:p>","DOI":"10.1371\/journal.pone.0315752","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T18:25:25Z","timestamp":1734459925000},"page":"e0315752","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Standardized evaluation of diabetic retinopathy using artificial intelligence and its association with metabolic dysfunction-associated steatotic liver disease in Japan: A cross-sectional study"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0917-2760","authenticated-orcid":true,"given":"Koji","family":"Komatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-8467","authenticated-orcid":true,"given":"Kota","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Tatemichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-1991","authenticated-orcid":true,"given":"Tadashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"pone.0315752.ref001","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"56","author":"K Tokushige","year":"2021","journal-title":"J Gastroenterol"},{"key":"pone.0315752.ref002","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non\u2010alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"N Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"pone.0315752.ref003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"key":"pone.0315752.ref004","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4254\/wjh.v10.i7.474","article-title":"Associations between nonalcoholic fatty liver disease and ischemic stroke","volume":"10","author":"S Alkagiet","year":"2018","journal-title":"World J Hepatol"},{"key":"pone.0315752.ref005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000493580","article-title":"Diabetic retinopathy as a risk factor associated with the development of hepatocellular carcinoma in nonalcoholic fatty liver disease","volume":"37","author":"S Azuma","year":"2019","journal-title":"Dig Dis"},{"key":"pone.0315752.ref006","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/jdi.13489","article-title":"Association of non-alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: a meta-analysis of observational studies","volume":"12","author":"D Song","year":"2021","journal-title":"J Diabetes Investig"},{"key":"pone.0315752.ref007","doi-asserted-by":"crossref","first-page":"1019899","DOI":"10.3389\/fmolb.2022.1019899","article-title":"The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: a meta-analysis of observational studies","volume":"9","author":"GH Zhang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"pone.0315752.ref008","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-011-2199-0","article-title":"Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS)","volume":"54","author":"R Kawasaki","year":"2011","journal-title":"Diabetologia"},{"key":"pone.0315752.ref009","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00417-022-05839-8","article-title":"Secular trends in the prevalence, incidence, and progression of diabetic retinopathy: the Hisayama Study","volume":"261","author":"S Hashimoto","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"pone.0315752.ref010","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"PS Dulai","year":"2017","journal-title":"Hepatology"},{"key":"pone.0315752.ref011","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41433-021-01912-4","article-title":"Comparison of early diabetic retinopathy staging in asymptomatic patients between autonomous AI-based screening and human-graded ultra-widefield colour fundus images","volume":"36","author":"A Sedova","year":"2022","journal-title":"Eye (Lond)"},{"key":"pone.0315752.ref012","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/aos.14306","article-title":"Evaluation of a deep learning system for the joint automated detection of diabetic retinopathy and age-related macular degeneration","volume":"98","author":"C Gonz\u00e1lez-Gonzalo","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"pone.0315752.ref013","doi-asserted-by":"crossref","first-page":"19742","DOI":"10.1038\/s41598-023-47270-x","article-title":"Associated factors of diabetic retinopathy by artificial intelligence evaluation of fundus images in Japan","volume":"13","author":"K Komatsu","year":"2023","journal-title":"Sci Rep"},{"key":"pone.0315752.ref014","unstructured":"[Cited 17 August 2024]. https:\/\/www.mhlw.go.jp\/content\/10900000\/001081581.pdf"},{"key":"pone.0315752.ref015","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/jpm13071148","article-title":"Retinal vascular lesions in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"13","author":"M Orfanidou","year":"2023","journal-title":"J Pers Med"},{"key":"pone.0315752.ref016","doi-asserted-by":"crossref","first-page":"e001189","DOI":"10.1136\/bmjdrc-2020-001189","article-title":"Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes","volume":"8","author":"Y Hashimoto","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"pone.0315752.ref017","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3390\/jcm9072083","article-title":"Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: a Japanese retrospective cohort study","volume":"9","author":"H Tanabe","year":"2020","journal-title":"J Clin Med"},{"key":"pone.0315752.ref018","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2169\/internalmedicine.51.7307","article-title":"Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study","volume":"51","author":"Y Takeuchi","year":"2012","journal-title":"Intern Med"},{"key":"pone.0315752.ref019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13340-011-0061-8","article-title":"Increased prevalence of diabetic complications in Japanese patients with type 1 diabetes and nonalcoholic fatty liver disease","volume":"3","author":"C Yoneda","year":"2012","journal-title":"Diabetol Int"},{"key":"pone.0315752.ref020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/dmrr.1012","article-title":"Diabetes in Japan: a review of disease burden and approaches to treatment","volume":"25","author":"SE Neville","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"pone.0315752.ref021","doi-asserted-by":"crossref","first-page":"36725","DOI":"10.1038\/srep36725","article-title":"Ethnic differences in glucose homeostasis markers between the Kyushu-Okinawa population study and the Framingham offspring study","volume":"6","author":"H Ikezaki","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0315752.ref022","first-page":"689","article-title":"Serum butyrylcholinesterase activities in patients with non-alcoholic fatty liver disease. Comparison with liver proteosynthetic function and liver fibrosis","volume":"122","author":"L Turecky","year":"2021","journal-title":"Bratisl Lek Listy"},{"key":"pone.0315752.ref023","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1011098829378","article-title":"Acetyl- and butyrylcholinesterase in normal and diabetic rat retina","volume":"26","author":"G S\u00e1nchez-Ch\u00e1vez","year":"2001","journal-title":"Neurochem Res"},{"key":"pone.0315752.ref024","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"H Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"pone.0315752.ref025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep4.1158","article-title":"Tumor necrosis factor-\u03b1-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice","volume":"2","author":"Y Osawa","year":"2018","journal-title":"Hepatol Commun"},{"key":"pone.0315752.ref026","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"J Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"pone.0315752.ref027","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.23104","article-title":"Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice","volume":"50","author":"CH Osterreicher","year":"2009","journal-title":"Hepatology"},{"key":"pone.0315752.ref028","doi-asserted-by":"crossref","first-page":"213130","DOI":"10.1155\/2013\/213130","article-title":"Inflammation and pharmacological treatment in diabetic retinopathy","volume":"2013","author":"S Ka\u0161telan","year":"2013","journal-title":"Mediators Inflamm"},{"key":"pone.0315752.ref029","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/db22-0515","article-title":"Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy","volume":"72","author":"S Dionysopoulou","year":"2023","journal-title":"Diabetes"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T18:25:34Z","timestamp":1734459934000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315752"}},"subtitle":[],"editor":[{"given":"Anna","family":"Di Sessa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0315752","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}